Thursday, November 3, 2016 | 9:00 AM - 5:00 PM
Speakers: Henrik Bjørn Nielsen (Clinical-Microbiomics A/S), Martin J. Blaser (New York University Langone Medical Center), Patrice D. Cani (Louvain Drug Research Institute, Metabolism and Nutrition), Rachel Carmody (Harvard University), Stanley L. Hazen (Cleveland Clinic), Gerald I. Shulman (Yale University School of Medicine), Marion Soto (Joslin Diabetes Center, Harvard Medical School), and Dan Winer (University of Toronto)
The microbiome is emerging as an important regulator of health, and disease well beyond the digestive tract. This symposium will highlight recent research innovations and therapeutic applications from the microbiome with a focus on metabolic disease.
Thursday, September 8, 2016 | 9:00 AM - 5:00 PM
Speakers: Hans-Joachim Anders (University of Munich), John Cijiang He (Icahn School of Medicine at Mount Sinai), Matthias Kretzler (University of Michigan), Kevin V. Lemley (University of Southern California), Jochen Reiser (Rush University Medical Center), Myung K. Shin (Merck & Co. Inc.), Katalin Susztak (University of Pennsylvania), and Roger C. Wiggins (University of Michigan)
Accumulating evidence supports a role for renal inflammation and podocytopathy in pathogenesis and progression of chronic kidney disease. This symposium will delve into the mechanisms underlying this pathology.
Tuesday, June 28, 2016 | 8:00 AM - 5:30 PM
Keynote Speaker: Giancarlo Comi (Università Vita-Salute San Raffaele)
Explore novel and emerging treatments for multiple sclerosis, including biomarkers and MRI usage in disease diagnosis, prognosis, and monitoring.
Monday, June 13, 2016 | 10:00 AM - 3:30 PM
Speakers: Ruslan M. Medzhitov (Yale School of Medicine, Howard Hughes Medical Institute), Mauro Perretti (The William Harvey Research Institute, Queen Mary University of London), Charles N. Serhan (Brigham and Women's Hospital & Harvard Medical School), Lars Klareskog (Karolinska Institutet), and Kevin J. Tracey (The Feinstein Institute for Medical Research)
This symposium will honor Dr. Charles N. Serhan, the recipient of the 2016 Ross Prize in Molecular Medicine, for his important discoveries in identifying bioactive mediators and cellular pathways critical in the resolution of inflammatory diseases.
Friday, June 3, 2016 | 8:30 AM - 6:00 PM
Speakers: Agnes C. Agunos (Public Health Agency of Canada), Seamus Fanning (University College Dublin), Delia Grace (International Livestock Research Institute), William J. Hall (Wellcome Trust), Francois Malouin (Sherbrooke University), James L. Marsden (Chipotle Mexican Grill), Alan G. Mathew (Purdue University), H. Morgan Scott (Texas A&M University), Stacy E. Sneeringer (USDA), Jaap A. Wagenaar (Utrecht University), and David R. Wolfgang (Pennsylvania State University)
Antibiotics have been used in human and animal medicine for decades. Reducing the use of antibiotics changes the dynamic between the food supply, food safety, and public health. Food safety practices may emerge a catalyst for change.
Edited by Mone Zaidi
(Mount Sinai School of Medicine, New York, New York)
Original research and review manuscripts covering topics in basic and translational bone and bone marrow biology.
Edited by Sonia Sequeira
(Memorial Sloan Kettering Cancer Center)
This Annals special issue presents advances in interdisciplinary research exploring the neural correlates and clinical applications of the practice of meditation.
Edited by Karin Moelling (University of Zurich)
Discussions of the link between nutrition and the gut microbiome
Organizers: John Hambor (Boehringer Ingelheim), Sarkis Mazmanian (California Institute of Technology), Nilufer Seth (Pfizer), Erick Young (Boehringer Ingelheim), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)
This eBriefing discusses gut–brain interactions and the possibility of targeting the microbiome with a focus on CNS health.